Patents Assigned to Lester Smith Medical Research Institute
  • Publication number: 20170335868
    Abstract: Disclosed is a system and method for aiding the sterility of a laboratory by suspending items using magnetic force to a laboratory object, such as a cap or a lid, wherein such cap may be suspended on a rack or stand comprising an arm extending horizontally. The system allows for suspension of items rather than placing them on surfaces, which may lead to contamination. The system may further prevent mixing of lids by increasing organizational capability by magnetic suspension of the caps or lids. The disclosed system supports a wide variety of scenarios for laboratory settings and related products and services.
    Type: Application
    Filed: January 12, 2017
    Publication date: November 23, 2017
    Applicant: Lester Smith Medical Research Institute
    Inventors: Ramon Coronado, Lauren E. Cornell
  • Publication number: 20170333906
    Abstract: Disclosed is a system and method for aiding the sterility of a laboratory by suspending items using magnetic force to a laboratory object, such as a cap or a lid, wherein such cap may be suspended on a rack or stand comprising an arm extending horizontally. The system allows for suspension of items rather than placing them on surfaces, which may lead to contamination. The system may further prevent mixing of lids by increasing organizational capability by magnetic suspension of the caps or lids. The disclosed system supports a wide variety of scenarios for laboratory settings and related products and services.
    Type: Application
    Filed: January 3, 2017
    Publication date: November 23, 2017
    Applicant: Lester Smith Medical Research Institute
    Inventors: Ramon Coronado, Lauren E. Cornell
  • Publication number: 20170326105
    Abstract: Disclosed is an improved composition characterized in containing a combination of melatonin and 5-HTP in a nasal administration for the rapid treatment of insomnia, anxiety, and related disorders in mammals, including humans. The present invention relates also to a pharmaceutical composition comprising 5-HTP and melatonin which utilizes the known effects of two substances to provide sleep improvement, relaxation, and reduced anxiety via rapid delivery of the combination, via nasal administration, for short-term alleviation of sleep disorder and anxiety-related symptoms. The combined effects of 5-HTP and melatonin in the present invention provide a short-term increase in blood plasma levels of melatonin while simultaneously increasing the production of serotonin for purposes of achieving natural melatonin biosynthesis in combination with the increased melatonin content in blood plasma.
    Type: Application
    Filed: May 10, 2017
    Publication date: November 16, 2017
    Applicant: The Lester Smith Medical Research Institute, LLC
    Inventor: Ramon Coronado